Sign in

CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company

Amylyx Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464600503
Phone
617-682-0917
Business address
55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
  1. 4 Open-market sale 10% owner sold 29,048 shares at $30.45 ($884,512)
  2. 4 Open-market sale 10% owner sold 160,964 shares at an average $30.42 ($4,896,561)
  3. 4/A Open-market sale Chief Financial Officer sold 32,500 shares at an average $31.89 ($1,036,459)
  4. 4/A Open-market sale Chief Medical Officer sold 54,627 shares at an average $31.87 ($1,741,200)
  5. 4 Open-market sale 10% owner sold 63,448 shares at an average $31.91 ($2,024,494)
  6. 8-K Event Executive or director change
  7. 4 Open-market sale Co-Chief Executive Officer sold 100,000 shares at an average $31.86 ($3,186,236)
  8. 4 Grant or award Chief Commercial Officer acquired 18,333 shares (grant or award)
  9. 4 Open-market sale Director sold 35,000 shares at an average $31.89 ($1,116,072)
  10. 4 Open-market sale Chief Medical Officer sold 54,627 shares at an average $31.87 ($1,741,200)
  11. 4 Grant or award Chief Legal Officer acquired 18,333 shares (grant or award)
  12. 4 Open-market buy Director bought 1,000 shares at $31.99 ($31,990)
  13. 4 Open-market sale Co-Chief Executive Officer sold 100,000 shares at an average $31.86 ($3,186,336)
  14. 4 Open-market sale Chief Financial Officer sold 32,500 shares at an average $31.89 ($1,036,459)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale 10% owner sold 9,122 shares at $32.55 ($296,921)
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 16 of 23 · 446 filings